Cerluten A-5 is a tissue-derived peptide bioregulator complex associated with brain and CNS research materials in the Khavinson programme. It is not a single defined molecule: no verified PubChem CID, CAS number, molecular formula, or amino-acid sequence is indexed under the name Cerluten. Supplied as Capsules Dry-Fill, 10 mg per capsule, 60 capsules per bottle.
$68.00
Out of stock
Want to be notified when this product is back in stock?
Cerluten A-5 is a tissue-derived peptide bioregulator complex associated with brain and central nervous system research materials in the Khavinson peptide programme. Unlike defined short peptides such as Pinealon (Glu-Asp-Arg), Cerluten A-5 is not a single chemically defined molecule: no verified PubChem CID, CAS number, molecular formula, molecular weight, IUPAC name, or InChIKey is indexed under the name Cerluten.
Peer-reviewed programme reviews discuss peptide bioregulators as short peptides or tissue preparations studied in connection with gene expression and protein synthesis (PubMed 24003726; DOI 10.1007/s10522-009-9249-8). Those sources describe the class. They do not supply a PubChem compound record for Cerluten itself. Reasonable inference: analytical identity for Cerluten A-5 should be treated as lot-level characterization of a complex, not as confirmation of one sequence.
At Modern Aminos, Cerluten A-5 is supplied in one laboratory format:
Laboratories building peptide bioregulator panels often place Cerluten A-5 next to defined short peptides such as Pinealon and other listings in the bioregulators collection. For a plain-language walkthrough, see What Is Cerluten A-5? Peptide Bioregulator Complex Explained.
| Compound Name | Cerluten A-5 |
|---|---|
| Research Category | Tissue-derived peptide bioregulator complex (brain/CNS-associated); Khavinson peptide programme |
| Quantity / Formats Offered | 10 mg per capsule, 60 capsules per capsule bottle (Capsules Dry-Fill) |
| Identity class | Peptide complex (mixture). Not a single defined amino-acid sequence |
| Peptide Sequence | Not applicable — no single verified sequence under the name Cerluten |
| Synonyms / Alt Names | Cerluten; Cerluten A-5; peptide complex A-5 (catalogue-style designation) |
| CAS Number | None verified under the name Cerluten |
| PubChem CID | None — PubChem compound name lookup for Cerluten returns no CID |
| Chemical Formula | Not applicable for a multi-component peptide complex |
| Molecular Weight | Not applicable as a single MW; complexes are typically discussed as low-molecular-weight peptide fractions rather than one exact mass |
| IUPAC Name | None — not a single defined molecule |
| InChIKey | None verified under the name Cerluten |
| Related defined peptides (contrast only) | Pinealon = Glu-Asp-Arg, PubChem CID 10273502; Cortagen = Ala-Glu-Asp-Pro in Khavinson short-peptide literature (no Modern Aminos product page at drafting) |
Identity fields above state the absence of single-molecule registry data for Cerluten. Related cortex-complex literature (for example Cortexin) is cited in the research section and must not be read as a PubChem identity for Cerluten A-5. Lot documentation, when posted, appears in the Certificate of Analysis tab.
Published work tied to the wider peptide bioregulator programme discusses class-level ideas. None of the points below is a Cerluten-specific binding constant or crystal structure.
A PubMed search for the string Cerluten returns no indexed records. The citations below are peer-reviewed sources for the peptide bioregulator programme and for cortex-associated complexes or short peptides. They are not trials of Cerluten A-5 by name.
The useful comparison is chemical class, not a shared PubChem CID.
| Reference | Identity class | Sequence / registry | Notes |
|---|---|---|---|
| Cerluten A-5 | Peptide complex | No single sequence; no Cerluten PubChem CID | Capsules Dry-Fill, 10 mg × 60 |
| Pinealon | Defined tripeptide | Glu-Asp-Arg; CID 10273502 | Synthetic short peptide contrast |
| Cortagen | Defined tetrapeptide (literature) | Ala-Glu-Asp-Pro in Khavinson short-peptide literature | No public Modern Aminos product URL at drafting |
| Cortexin (literature) | Cortex polypeptide complex | Mixture; described in PubMed 31099784 | Related programme complex, not the Cerluten trade name |
| Cartalax (contrast) | Defined tripeptide | Ala-Glu-Asp; CID 87815447 | Often mislabeled as Cerluten in secondary sources — incorrect |
Browse additional listings in the bioregulators collection.
Cerluten A-5 is a tissue-derived peptide bioregulator complex associated with brain and central nervous system research materials in the Khavinson peptide programme. It is supplied as Capsules Dry-Fill research material at 10 mg per capsule, 60 capsules per bottle. It is not indexed in PubChem under the name Cerluten as a single compound.
In the peer-reviewed literature associated with V. Kh. Khavinson and colleagues, peptide bioregulators are short peptides or tissue-derived peptide preparations discussed as regulators of gene expression and protein synthesis. Reviews summarizing experimental and clinical programme results include Advances in Gerontology communications and related Biogerontology work. Those publications describe a research class; they do not establish a single PubChem identity for Cerluten A-5.
Tissue-derived peptide complexes are mixtures of low-molecular-weight peptides isolated from a source tissue and therefore lack one amino-acid sequence, one molecular formula, and one PubChem CID. Synthetic short peptides are single, chemically defined sequences that can be listed in PubChem with CAS, formula, and molecular weight. Reasonable inference: analytical expectations differ because a complex has no single-sequence assay target, while a defined peptide can be matched to one structure.
No. Pinealon is the defined tripeptide Glu-Asp-Arg (PubChem CID 10273502). Cortagen is described in the Khavinson short-peptide literature as Ala-Glu-Asp-Pro. Cerluten A-5 is named as a peptide complex, not as either of those sequences, and it has no verified single-sequence PubChem record under the Cerluten name.
No verified PubChem CID, CAS number, molecular formula, molecular weight, IUPAC name, or InChIKey is indexed under the name Cerluten. A PubChem compound name lookup for Cerluten returns no CID, and a PubMed search for Cerluten returns no indexed records. Do not treat Ala-Glu-Asp (Cartalax) or other defined sequences as the identity of Cerluten A-5.
Peer-reviewed papers discuss Cortexin as a calf cerebral-cortex polypeptide complex and report short peptides studied in related work. Examples include Kuznik et al., Molecular Biology (2019), PubMed 31099784, and Umnov et al., Bulletin of Experimental Biology and Medicine (2014), PubMed 25257443. Those citations concern Cortexin or defined short peptides; they are related programme literature, not trials of the trade name Cerluten.
A-5 is the catalogue-style designation used with the Cerluten A-5 name for this brain/CNS peptide-complex research material. It is a product-line code, not a PubChem identifier and not proof of a single amino-acid sequence.
For a defined peptide, a certificate can support identity against a stated sequence and mass. For a peptide complex, there is no single sequence specification to match, so a certificate may characterize a lot (for example by chromatographic profile or other applicable tests) without establishing that two lots are the same single molecule. All applicable tests are performed on our products; current certificates are listed in the Certificate of Analysis tab and can be looked up on our COA Search page.
Cerluten A-5 is offered as Capsules Dry-Fill: 10 mg per capsule, 60 capsules per bottle. Capsule products are not intended for time-release and are for transport only.
All applicable tests are performed on our products. Certificates of analysis can be looked up on our COA Search page, and the current third-party certificate is published in the Certificate of Analysis tab when available. See also why HPLC testing matters.
Capsule products are not intended for time-release and are for transport only.
DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.
